John Valliant, Chief Executive Officer at Fusion Pharmaceuticals Inc. (FUSN), sold 14,504 shares at $7.32 ($104K) on 2022-03-04, disclosed to the SEC on 2022-03-08.
Open-market sale of $104k FUSN by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.32 | 8,400 | $61K | 59.2% |
| 2 | $6.99 | 3,100 | $22K | 20.8% |
| 3 | $6.92 | 3,004 | $21K | 20.0% |
| Total | $7.17 avg | 14,504 | $104K | 100% |
| Filing → |
| FUSN | SELL | 2022-04-13 | $432K | — | Filing → |
| FUSN | SELL | 2022-04-08 | $16K | — | Filing → |
| FUSN | SELL | 2022-04-05 | $29K | — | Filing → |